Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOPPIT
2023-509863-26-00Phase 4Authorised
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Cirrhosis comparing Continue Nexium with Stop Nexium (placebo) (2 arms). Planned start Jun 2024; status: authorised.
02
Drugs
esomeprazole
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on 2023-509863-26-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-509863-26-00.